Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Plunkett's Pharmaceuticals is an Australian-owned pharmaceutical company specializing in the development and distribution of therapeutic skincare and health products. Founded by pharmacist John Plunkett, the company is best known for its flagship "Superfade" range, which utilizes pharmaceutical-grade ingredients to treat skin pigmentation and age spots. The company also produces the NS (Nutricare Systems) line, which focuses on natural-based, intensive treatments for dry, sensitive, and damaged skin conditions such as cracked heels and eczema. Plunkett's emphasizes evidence-based formulations that bridge the gap between cosmetic skincare and clinical pharmaceutical treatments. Their products are widely available through pharmacy networks in Australia and select international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Plunkett's.